8-K: Philip Morris International Announces Quarterly Dividend of $1.35 Per Share

Philip Morris International has declared a regular quarterly dividend of $1.35 per common share, payable on January 13, 2025, to shareholders of record as of December 26, 2024.

Summary

• Philip Morris International (PMI) has announced a regular quarterly dividend of $1.35 per common share.
• The dividend is payable on January 13, 2025, to shareholders of record as of December 26, 2024.
• The ex-dividend date is also December 26, 2024.
• PMI is focused on delivering a smoke-free future and is evolving its portfolio to include products outside of the tobacco and nicotine sector.
• Since 2008, PMI has invested over $12.5 billion in developing and commercializing smoke-free products.
• PMI's smoke-free products are available in 90 markets as of June 30, 2024.
• An estimated 36.5 million adults globally use PMI's smoke-free products.
• The smoke-free business accounted for approximately 38% of PMI's total net revenues for the first nine months of 2024.
• PMI acquired Swedish Match in 2022, creating a global smoke-free champion.
• PMI aims to expand into wellness and healthcare areas.

Sentiment

Score: 8

Explanation: The document conveys a positive outlook with a focus on shareholder returns through dividends and strategic investments in smoke-free products and future growth areas. The company's commitment to a smoke-free future and expansion into wellness and healthcare are also positive indicators.

Positives

• The declaration of a regular quarterly dividend of $1.35 per share provides a return to shareholders.
• PMI's significant investment of over $12.5 billion in smoke-free products demonstrates a commitment to innovation and future growth.
• The expansion of smoke-free products to 90 markets indicates a strong global presence.
• The 36.5 million users of PMI's smoke-free products shows a growing market acceptance.
• The 38% contribution of smoke-free products to net revenues highlights the success of the company's strategic shift.
• PMI's ambition to expand into wellness and healthcare areas suggests potential for diversification and new revenue streams.

Risks

• Renewal applications for IQOS products are pending before the FDA, which could impact future sales if not approved.
• The company's reliance on the tobacco and nicotine sector, despite the shift to smoke-free products, still exposes it to regulatory and health-related risks.
• The expansion into wellness and healthcare is a new area for PMI and may present challenges in terms of expertise and market competition.

Future Outlook

PMI aims to continue its transition towards a smoke-free future and expand into wellness and healthcare areas, leveraging its expertise in life sciences.

Management Comments

• PMI is actively delivering a smoke-free future and evolving its portfolio for the long term.
• PMI is committed to ending the sale of cigarettes.
• PMI aims to enhance life through the delivery of seamless health experiences.

Industry Context

The announcement aligns with the broader industry trend of tobacco companies diversifying into smoke-free alternatives and exploring new growth areas such as wellness and healthcare, reflecting a response to changing consumer preferences and regulatory pressures.

Comparison to Industry Standards

• PMI's investment of $12.5 billion in smoke-free products is significant compared to other tobacco companies, demonstrating a strong commitment to this sector.
• The 38% revenue contribution from smoke-free products is a notable achievement, indicating a successful transition compared to competitors who may have a lower percentage.
• The acquisition of Swedish Match positions PMI as a leader in the oral nicotine delivery market, a strategic move that differentiates it from some competitors.
• PMI's expansion into wellness and healthcare is a forward-looking strategy, similar to some other large companies in the consumer goods space, but is still in its early stages.

Stakeholder Impact

• Shareholders will receive a regular quarterly dividend of $1.35 per share.
• Employees may benefit from the company's growth in new sectors.
• Customers will have access to a wider range of smoke-free products.
• Suppliers may see increased demand for materials related to smoke-free products.
• Creditors will see a stable company with a commitment to future growth.

Next Steps

• The dividend will be paid on January 13, 2025.
• PMI will continue to develop and commercialize smoke-free products.
• PMI will pursue its expansion into wellness and healthcare areas.
• PMI will continue to seek regulatory approvals for its smoke-free products.

Key Dates

Keywords

dividend, smoke-free products, tobacco, Philip Morris International, IQOS, Swedish Match, ZYN, wellness, healthcare, FDA